BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification.
about
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesSWI/SNF chromatin remodeling complexes and cancerMiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells.Downregulation of MiR-30a is Associated with Poor Prognosis in Lung CancerThe BCL11A-XL expression predicts relapse in squamous cell carcinoma and large cell carcinoma.Genetic polymorphisms and plasma levels of BCL11A contribute to the development of laryngeal squamous cell carcinoma.miRiaD: A Text Mining Tool for Detecting Associations of microRNAs with Diseases.Identification of More Feasible MicroRNA-mRNA Interactions within Multiple Cancers Using Principal Component Analysis Based Unsupervised Feature Extraction.Comparative analysis of hepatocellular carcinoma and cirrhosis gene expression profiles.A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma.Protein-coding genes, long non-coding RNAs combined with microRNAs as a novel clinical multi-dimension transcriptome signature to predict prognosis in ovarian cancermiR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study.The expression pattern of Bcl11a, Mdm2 and Pten genes in B-cell acute lymphoblastic leukemia.High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: an anti-tumor effect of TLR5 signaling in non-small cell lung cancer.
P2860
Q26748881-3B25DCE9-EAA1-4DD6-AF24-9E630611B64EQ26998657-4166EE95-1A15-41A7-A0F1-730B566435C5Q34993681-C2568E67-A21C-461B-AF87-D750C1F31DC8Q35114304-DD249E62-097F-4620-ACB4-519509CEDDD1Q36010194-0498E7C2-33EB-4CC0-AC6F-0CEA7C6629A7Q36138285-EE19B553-C6D8-48E1-A03A-9D7BCF208C64Q36287371-6983CD0B-DE1E-4715-81B2-DE8EE15C9B8FQ36928979-06F9B07C-D10F-4F4C-97DF-6B06D7BD0ECDQ36939247-D5506DD4-138E-4D0A-8D29-DE09BF11701FQ39105585-80E9EBC3-4F01-4803-9572-7E2D94EAA1B6Q41367937-1D64136F-0DEC-420A-ABE8-2B048A65A227Q42700731-8DCEB9AD-3F86-4944-8C12-627A0E0F15F0Q50157898-3E609D1A-EABE-43D4-98FF-4C8AAB4F8EACQ50201177-E6F03293-BCD3-4164-B3C2-D9ADE211A9CAQ50720651-216A13BE-1D7E-4880-9387-34B67963215A
P2860
BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
BCL11A overexpression predicts ...... NA-30a and gene amplification.
@en
type
label
BCL11A overexpression predicts ...... NA-30a and gene amplification.
@en
prefLabel
BCL11A overexpression predicts ...... NA-30a and gene amplification.
@en
P2093
P2860
P356
P1433
P1476
BCL11A overexpression predicts ...... RNA-30a and gene amplification
@en
P2093
Ben-yuan Jiang
Jin-ji Yang
Shi-liang Chen
Xu-chao Zhang
Xue-ning Yang
Zhi-hong Chen
P2860
P2888
P356
10.1186/1476-4598-12-61
P50
P577
2013-06-12T00:00:00Z
P5875
P6179
1042917883